
Acadia Healthcare Company, Inc.
ACHCNasdaqCIK 1520697HealthcareFiscal year ends Dec 31
Reports and events: 300 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0217:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001637 |
| 2023-10-3016:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-266248 |
| 2023-10-2616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-264094 |
| 2023-10-1117:09 ET | 8-K | 8.01 Other events | 0001193125-23-254205 |
| 2023-07-2816:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-035484 |
| 2023-07-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001176 |
| 2023-07-1116:05 ET | 8-K | 8.01 Other events | 0001157523-23-001076 |
| 2023-07-0517:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-182040 |
| 2023-06-0217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-159929 |
| 2023-05-1917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-149461 |
| 2023-04-2716:19 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-015296 |
| 2023-04-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-000620 |
| 2023-04-0716:01 ET | DEF 14A | Proxy statement | 0001140361-23-017321 |
| 2023-02-2816:14 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001564590-23-002737 |
| 2023-02-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-000366 |
| 2022-12-0708:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-22-001710 |
| 2022-11-0213:48 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001564590-22-036269 |
| 2022-11-0107:23 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-22-001454 |
| 2022-10-3116:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-22-001443 |
| 2022-07-2816:45 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-026910 |
| 2022-07-2716:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-22-000932 |
| 2022-06-2917:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-185179 |
| 2022-05-2018:12 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-155213 |
| 2022-05-0416:27 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-017872 |
| 2022-05-0316:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-22-000544 |
| 2022-04-0806:05 ET | DEF 14A | Proxy statementPeriod 2022-05-19 | 0001140361-22-013667 |
| 2022-04-0417:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001157523-22-000389 |
| 2022-03-0113:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-007930 |
| 2022-02-2816:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-22-000270 |
| 2022-02-0116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-024575 |
| 2021-10-2916:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-052945 |
| 2021-10-2816:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-21-001282 |
| 2021-10-0508:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001157523-21-001181 |
| 2021-08-0316:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-040250 |
| 2021-08-0216:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-21-000964 |
| 2021-05-0717:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-21-155064 |
| 2021-04-3016:18 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-022545 |
| 2021-04-2916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-21-000547 |
| 2021-03-2417:01 ET | DEF 14A | Proxy statementPeriod 2021-05-06 | 0001193125-21-092741 |
| 2021-03-2208:46 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-088596 |
| 2021-02-2616:33 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-009466 |
| 2021-02-2617:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-21-000271 |
| 2021-01-2220:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-013858 |
| 2021-01-2116:32 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-21-013526 |
| 2021-01-0716:04 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-21-004146 |
| 2020-12-3008:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-329213 |
| 2020-12-1117:14 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-20-134817 |
| 2020-11-1316:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-20-293046 |
| 2020-10-3016:11 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-049309 |
| 2020-10-2916:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-20-001384 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 17:50 ET. Listed shows no prices and gives no investment advice.